Crl

CROs Face Stagnant Preclinical Market Growth

CROs Face Stagnant Preclinical Market Growth

By Zachary Brennan

An uptick in the outsourcing of preclinical trials is expected as pharmaceutical companies look to restructure and cut costs, but that increase won't necessarily begin in 2013, according to an analyst.

Spotlight

Follow us

Featured Events

View more

Products

View more

Webinars

Featured Suppliers

All suppliers